BCL2 and metabolic dysfunction-associated steatotic liver disease: Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are both characterized by liver injury and inflammation, which are driven in part by excessive apoptosis of hepatocytes due to low BCL2 expression [141,142].